EPIX News

EpiVax y la FDA publican nuevos hallazgos sobre la teriparatida genérica USA - español USA - Deutsch USA - English USA - English APAC - English USA - Français

New EMA Research Examines Network Source of Truth (NSoT) Strategies as Adoption Accelerates

EpiVax et les scientifiques de la FDA publient de nouvelles informations sur les risques d'immunogénicité des impuretés liées aux peptides dans le tériparatide générique USA - Français USA - English USA - English APAC - English

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide USA - English USA - English

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

ESSA Announces Completion of Arrangement with XenoTherapeutics

ESSA Securityholders Approve Acquisition by XenoTherapeutics

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order

ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025